Company / Gross Margin
PROCEPT BioRobotics Corp Gross Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
63.7%
FY2025
5-year range
46.0% / 63.7%
FY2021-FY2025
Trend
+4.3%
vs FY2024
Sector context
#34 of 93
Health Care
What the data says
At 63.7%, PROCEPT BioRobotics Corp's gross margin ranks #34 of 93 in the Health Care sector. Gross Margin has increased for 5 consecutive years, from -16.3% in FY2020 to 63.7% in FY2025.
Based on SEC 10-K filings.
63.7% in FY2025 with a 5-year CAGR of +80.0%.
Improved from 52.2% to 63.7% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +14.3pp
- 5-Year Change
- +80.0pp
- 10-Year Change
- -
Sector benchmark
#34 of 93 in Health CareTop 37% of 93This company 63.7% Sector average 53.0%
▼
+20.2% above sector average
Key checks
Key Insights
- PROCEPT BioRobotics Corp's gross margin has grown for 5 consecutive years.
- In FY2025, gross margin increased 4.3% year-over-year.
- Currently 10.7pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 63.7% | +4.3% |
| FY2024 | 61.1% | +17.1% |
| FY2023 | 52.2% | +5.5% |
| FY2022 | 49.4% | +7.4% |
| FY2021 | 46.0% | +383.0% |
| FY2020 | -16.3% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026